Search results
John Charles Martin (May 7, 1951 – March 30, 2021) was an American billionaire businessman, and the former executive chairman (2016–2018) and CEO (1996–2016) of the American biotechnology company Gilead Sciences.
27 Apr 2021 · John C. Martin, who became a billionaire by developing and marketing a daily single-dose pill that transformed H.I.V. into a manageable disease and who popularized another drug that cures...
John C. Martin was an unassuming man with an ordinary name. But his leadership qualities and accomplishments as a biopharma CEO were extraordinary. Martin, the CEO of Foster City, Calif.-based Gilead Sciences from 1996 to 2016, didn’t seek to dominate the room or inspire legions with a charismatic personality.
1 Apr 2021 · Scripps Research mourns the loss of board member and global health leader John C. Martin. Martin, former CEO and executive chairman of Gilead Sciences, made pivotal impacts on global public health over the course of an impressive career spanning science and business. April 01, 2021.
31 Mac 2021 · FOSTER CITY, Calif.-- ( BUSINESS WIRE )--Gilead Sciences, Inc. (Nasdaq: GILD) today released the following statement on the death of John C. Martin, PhD, who served as the company’s chief...
7 Apr 2021 · John C. Martin, former CEO of Gilead Sciences who helped develop the first once-a-day pill to treat HIV while at the helm of the company, died unexpectedly on March 30 after suffering head injuries from a fall the previous day. He was 69.
On 30 March 2021, John C. Martin, former executive chairman and CEO of Gilead Sciences, has passed away. Dr. Martin was one of the key figures without whom some of the most important antivirals used to combat HIV or HBV, originating in Antonín Holý’s lab at IOCB Prague, would never exist.
